Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorThe First Affiliated Hospital of University of South China

About this trial

Percutaneous nephrolithotomy(PCNL) is a surgical method for upper urinary calculi. The advent of tubeless PCNL (without indwelling nephrostomy tube) has been proved to be safe and effective in reducing postoperative discomfort, shortening hospitalization time and reducing hospitalization costs. Traditional tubeless PCNL usually involves retrograde insertion of the ureteral catheter, which may cause many ureteral related surgical complications. However, there are few reports on tubeless PCNL without reverse ureteral catheter insertion. The goal of this study is to explore the safety and effectiveness of the tubeless PCNL without reverse ureteral catheter insertion.

Eligibility criteria

Qualifiers

Participants who met the the applications of PCNL surgery in the 2019 Chinese Guidelines for the Diagnosis and Treatment of Urological Diseases

Participants who agree to undergo tubeless PCNL

The participants' maximum diameter of the stone should be less than 3.5cm

Disqualifiers

Confirmation by computerized tomography (CT) images and blood biochemical indicators of infectious stones or complex staghorn stones

Obvious surgical contraindications, such as severe heart and lung insufficiency, abnormal coagulatory function

Previous PCNL or nephrolithotomy, presence of an indwelling ureteral stent or nephrostomy tube before surgery

Renal trauma or congenital malformation of the urinary system

Trial design

Treatments tested in this trial

  • Without reverse insertion of a ureteral catheter

Treatment groups

200 Participants
are divided into 2 treatment groups